(Total Views: 730)
Posted On: 07/30/2022 9:17:29 AM
Post# of 148899
it sounds like most on the board will vote yes. so maybe this is a moot post. i maintain that we're not going to have any earth-shattering news prior to the vote - but maybe we will - who knows. my 2 points are:
1. the new team is controlling what they can control. they have cut costs on trials (moving toward a partnership approach which will come at some point). they have also cut the marketing costs (although i do miss seeing Christine Corrado
), and have cut compensation costs. in other words, they are running a tight ship financially.
2. what they cannot control is the timing of the clinical hold lift - the FDA has to ulimately clear that, unfortunately, and we know how that beauracracy works. i really hope the FDA doesn't slow walk us on this - but again, we are somewhat at their mercy.
that said, i would love to hear from Cyrus - just to see his face, hear his voice, and see his enthusiasm for our drug and the path forward.
1. the new team is controlling what they can control. they have cut costs on trials (moving toward a partnership approach which will come at some point). they have also cut the marketing costs (although i do miss seeing Christine Corrado
), and have cut compensation costs. in other words, they are running a tight ship financially. 2. what they cannot control is the timing of the clinical hold lift - the FDA has to ulimately clear that, unfortunately, and we know how that beauracracy works. i really hope the FDA doesn't slow walk us on this - but again, we are somewhat at their mercy.
that said, i would love to hear from Cyrus - just to see his face, hear his voice, and see his enthusiasm for our drug and the path forward.
(8)
(0)Scroll down for more posts ▼
